Last week, two cannabis-based treatments for epilepsy and multiple sclerosis were approved by the NHS. As part of a wider focus on cannabis-based products, the BBC interviewed Dr Tom Freeman, lead director of the Addiction and Mental Health Group at the University of Bath. Sativa’s Director of Regulatory Affairs, Dr Nick Horniman, is interviewed in the Group’s Phytovista laboratory.
To read the full news article please click here
Sativa Group Plc is the UK’s leading quoted CBD Wellness and medicinal cannabis group with five operating subsidiaries. Goodbody Botanicals provides CBD products online and to retail markets including pharmacies, wellness stores and grocers. Goodbody Wellness is a high-street retail brand with dedicated CBD Wellness stores providing a premium shopping experience to consumers. Tessellate Collective is a direct-selling network marketing platform servicing consumers at home. Phytovista laboratories provides independent testing of CBD products to both external customers and fellow Group businesses. Sativa Grow holds a Controlled Drug licence and cultivates cannabis plants to fulfil its partnership agreement with King’s College London to research the impact of cannabinoids on inflammation and respiratory conditions.
